Bioventus Inc. (NASDAQ: BVS) reported Q4 Revenue for the quarter came in at $153.64 million versus the consensus estimate of $145.16 million.

GUIDANCE:

Bioventus Inc. sees FY2025 EPS of $0.64-$0.68, versus the consensus of $0.55. Bioventus Inc. sees FY2025 revenue of $560-570 million, versus the consensus of $554.8 million.

For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.